Connor, Clark & Lunn Investment Management (CC&L)
ENZ

Connor, Clark & Lunn Investment Management (CC&L)’s Enzo Biochem, Inc. ENZ Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-64,109
Closed -$144K – 1157
2020
Q2 		$144K Buy
64,109
+39,563
+161% +$102K ﹤0.01% 929
2020
Q1 		$62K Buy
+24,546
New +$60.3K ﹤0.01% 961
2019
Q4 		– Sell
-11,175
Closed -$40K – 1120
2019
Q3 		$40K Buy
+11,175
New +$39.6K ﹤0.01% 938
2017
Q3 		– Sell
-20,820
Closed -$230K – 936
2017
Q2 		$230K Sell
20,820
-11,900
-36% -$111K ﹤0.01% 716
2017
Q1 		$274K Buy
32,720
+1,700
+5% +$12K ﹤0.01% 748
2016
Q4 		$215K Sell
31,020
-8,100
-21% -$51.7K ﹤0.01% 777
2016
Q3 		$199K Sell
39,120
-19,100
-33% -$114K ﹤0.01% 733
2016
Q2 		$348K Sell
58,220
-62,600
-52% -$347K ﹤0.01% 651
2016
Q1 		$550K Sell
120,820
-17,400
-13% -$77.4K ﹤0.01% 553
2015
Q4 		$622K Buy
138,220
+23,800
+21% +$101K 0.01% 512
2015
Q3 		$363K Buy
114,420
+22,100
+24% +$67.1K ﹤0.01% 573
2015
Q2 		$280K Buy
92,320
+700
+0.8% +$1.97K ﹤0.01% 507
2015
Q1 		$270K Buy
91,620
+12,100
+15% +$39.6K ﹤0.01% 468
2014
Q4 		$353K Buy
79,520
+6,100
+8% +$29.1K ﹤0.01% 439
2014
Q3 		$378K Buy
+73,420
New +$392K ﹤0.01% 423

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ENZ Position: Q3 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Enzo Biochem, Inc. (ENZ) in Q3 2020, closing a stake of 64,109 shares — an estimated $144K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ENZ in Q3 2014 and held it in 15 quarters. The position peaked at $622K in Q4 2015. 82 funds tracked by Wall St. Rank hold ENZ as of Q3 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Enzo Biochem, Inc. position as of Q3 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 64,109 Enzo Biochem, Inc. shares in Q3 2020, an estimated $144K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Enzo Biochem, Inc. in Q3 2014 and held it in 15 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Enzo Biochem, Inc. position peaked at $622K in Q4 2015.
  • 82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2020, filed 12 Nov 2020.